BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17975135)

  • 1. Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy.
    Plummer ER; Calvert H
    Clin Cancer Res; 2007 Nov; 13(21):6252-6. PubMed ID: 17975135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of poly(ADP-ribose) polymerase in cancer.
    Plummer ER
    Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
    Yap TA; Sandhu SK; Carden CP; de Bono JS
    CA Cancer J Clin; 2011; 61(1):31-49. PubMed ID: 21205831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA repair as a promising approach in cancer therapy.
    Damia G; D'Incalci M
    Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose)polymerase (PARP) inhibitors: from bench to bedside.
    Plummer R
    Clin Oncol (R Coll Radiol); 2014 May; 26(5):250-6. PubMed ID: 24602564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
    Ratnam K; Low JA
    Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Aminobenzamide delays rejoining of DNA strand breaks in gamma-irradiated lymphocytes from patients with breast cancer and not cervical cancer.
    Mukhopadhyay D; Anant S; Mukherji S
    Neoplasma; 1994; 41(3):151-7. PubMed ID: 7935983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of poly(ADP-ribose) in the DNA damage signaling network.
    Malanga M; Althaus FR
    Biochem Cell Biol; 2005 Jun; 83(3):354-64. PubMed ID: 15959561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.
    Lewis C; Low JA
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1051-6. PubMed ID: 18058575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents.
    Bryant HE; Helleday T
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):959-61. PubMed ID: 15506935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward specific functions of poly(ADP-ribose) polymerase-2.
    YĆ©lamos J; Schreiber V; Dantzer F
    Trends Mol Med; 2008 Apr; 14(4):169-78. PubMed ID: 18353725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
    Plummer R
    Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in poly(ADP-ribose) level modulate the kinetics of DNA strand break rejoining.
    Ryabokon NI; Goncharova RI; Duburs G; Hancock R; Rzeszowska-Wolny J
    Mutat Res; 2008 Jan; 637(1-2):173-81. PubMed ID: 17935742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted cancer therapies based on the inhibition of DNA strand break repair.
    O'Connor MJ; Martin NM; Smith GC
    Oncogene; 2007 Dec; 26(56):7816-24. PubMed ID: 18066095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors.
    Gaymes TJ; Shall S; Farzaneh F; Mufti GJ
    Haematologica; 2008 Dec; 93(12):1886-9. PubMed ID: 18838476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of poly (ADP-ribose) polymerase activity as correlates of DNA damage.
    Zhou Y; Liang S; Williams LR
    Methods Mol Biol; 2002; 203():247-55. PubMed ID: 12073447
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors.
    Branca D; Cerretani M; Jones P; Koch U; Orvieto F; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4042-5. PubMed ID: 19553107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
    Farmer H; McCabe N; Lord CJ; Tutt AN; Johnson DA; Richardson TB; Santarosa M; Dillon KJ; Hickson I; Knights C; Martin NM; Jackson SP; Smith GC; Ashworth A
    Nature; 2005 Apr; 434(7035):917-21. PubMed ID: 15829967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of base excision repair reactions by apoptotic 24kDa-fragment of poly(ADP-ribose) polymerase 1 in bovine testis nuclear extract.
    Sukhanova M; Khodyreva S; Lavrik O
    DNA Repair (Amst); 2007 May; 6(5):615-25. PubMed ID: 17236819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair pathways and their implication in cancer treatment.
    Pallis AG; Karamouzis MV
    Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.